DCGI Gives Nod To AstraZeneca Pharma India To Import, Market Selumetinib Capsules
Drug firm AstraZeneca Pharma India has received import and market permission from the Indian drug regulator for Selumetinib capsules. AstraZeneca Pharma India said in a regulatory filing, the company has…
Share